Advertisement
Advertisement

BRKR

BRKR logo

Bruker Corporation

59.41
USD
Sponsored
+0.39
+0.66%
Sep 03, 16:00 UTC -4
Closed
exchange

After-Market

59.41

0.00
-0.01%

Bruker Corporation Profile

About

Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.

Info & Links

CEO

Frank H. Laukien

Headquarters

40 Manning Road
Billerica, MA 01821, UNITED STATES

Industry

Instruments Scientific

Sector

Computer And Technology

Website

www.bruker.com

Auditor

PricewaterhouseCoopers LLP

Share holders

59

Employees

11,085

Bruker Corporation Statistics

Valuation Measures

Market Capitalization2

9.05B

Enterprise Value

10.69B

Enterprise Value/EBITDA(ttm)

53.59

Price to Earnings Ratio(ttm)

30.45

Price to Sales(ttm)

2.44

Price to Book(mrq)

3.55

Price to Cash(ytd)

16.60

Profitability

Gross Margin(ttm)

46.45%

Operating Margin(ttm)

8.72%

Profit Margin(ttm)

-3.20%

Return on Equity(ttm)

12.47%

Return on Invested Capital(ttm)

-1.47%

Return on Assets(ttm)

4.91%

Income Statement

Revenue(ttm)

3.50B

Revenue Per Share(ttm)

22.97

Gross Profit(ttm)

1.62B

EBITDA(ttm)3

199.50M

Net Income Available to Common(ttm)

-106.90M

Diluted EPS(ttm)

-0.70

Share Statistics

Beta (5Y Monthly)

1.26

52-Week Change

78.78%

S&P 500 52-Week Change

20.14%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

152.36M

Dividend Yield

0.36%

Float4

110.92M

% Held by Insiders

27.20%

% Held by Institutions

79.52%

Balance Sheet

Total Cash(mrq)

184.90M

Total Cash Per Share(mrq)

1.21

Total Debt(mrq)

1.82B

Total Debt/Equity(mrq)

76.03%

Current Ratio(mrq)

1.85%

Quick Ratio(mrq)

0.92%

Book Value Per Share(mrq)

15.75

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.04

Free Cash Flow(ytd)

-59.20M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement